Copyright
©The Author(s) 2020.
World J Exp Med. Apr 27, 2020; 10(3): 26-40
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
Figure 3 Proliferation of adipose-derived stromal cells in patients after received neoadjuvant chemotherapy treatment.
A: Growth curve of ASCs from the cancerous side (CA-ASC) of the breast in patients receiving neoadjuvant chemotherapy (+NAC) vs not-receiving neoadjuvant chemotherapy (-NAC) during 11 d culturing. B: Comparison of ASCs from the noncancerous side (N-ASC) of the breast vs cancerous side (CA-ASC) of the breast on cell proliferation between patients receiving NAC treatment and not-receiving NAC during 11 d culturing (n = 21, mean ± SE, P = NS). ASC: Adipose-derived stromal cell; NAC: Neoadjuvant chemotherapy.
- Citation: Hagaman AR, Zhang P, Koko KR, Nolan RS, Fromer MW, Gaughan J, Matthews M. Isolation and identification of adipose-derived stromal/stem cells from breast cancer patients after exposure neoadjuvant chemotherapy. World J Exp Med 2020; 10(3): 26-40
- URL: https://www.wjgnet.com/2220-315x/full/v10/i3/26.htm
- DOI: https://dx.doi.org/10.5493/wjem.v10.i3.26